Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Transdermal N-0923 effective in Parkinson's disease

May 6, 1997

COX-2 inhibitor shows potential for preventing neuronal death

May 6, 1997

Neuromyalgic response to rhNGF described

May 6, 1997

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

May 6, 1997

ABT-431 evaluated in Parkinson's patients

May 6, 1997

New ganciclovir derivative from Norsk Hydro for HSV infections

May 5, 1997

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Anti-HIV antisense oligonucleotides from Hybridon evaluated in SCID mice

May 5, 1997

Antisense oligonucleotides for RSV infection

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...